Thomas Bachleitner-Hofmann

No ORCID on file · 1 paper in corpus

other 2025

Surgical and oncological outcome after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma : A retrospective single center experience

Wiener klinische Wochenschrift ·doi:10.1007/s00508-024-02460-z

BACKGROUND: Peritoneal mesothelioma (PM) is a rare disease with various histopathological subtypes. For malignant peritoneal mesothelioma and borderline subgroups locoregional therapy with cytoreductive surgery (CRS) and hyperthermic intrap…